↓ Skip to main content

Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67

Overview of attention for article published in Breast Cancer Research, November 2011
Altmetric Badge

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67
Published in
Breast Cancer Research, November 2011
DOI 10.1186/bcr3068
Pubmed ID
Authors

Shinichiro Kashiwagi, Masakazu Yashiro, Tsutomu Takashima, Naoki Aomatsu, Katsumi Ikeda, Yoshinari Ogawa, Tetsuro Ishikawa, Kosei Hirakawa

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 4%
Japan 1 2%
Switzerland 1 2%
Unknown 50 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 24%
Student > Ph. D. Student 9 17%
Student > Bachelor 5 9%
Student > Master 5 9%
Other 5 9%
Other 11 20%
Unknown 6 11%
Readers by discipline Count As %
Medicine and Dentistry 23 43%
Agricultural and Biological Sciences 15 28%
Biochemistry, Genetics and Molecular Biology 5 9%
Immunology and Microbiology 1 2%
Business, Management and Accounting 1 2%
Other 2 4%
Unknown 7 13%